AGLX Fundamental Analysis - AGILYX ASA

Fundamental Rating

AGLX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 42 industry peers in the Commercial Services & Supplies industry. While AGLX seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, AGLX is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AGLX has reported negative net income.

AGLX had a negative operating cash flow in the past year.

In the past 5 years AGLX reported 4 times negative net income.

AGLX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of AGLX (-12.32%) is worse than 71.43% of its industry peers.

With a Return On Equity value of -17.15%, AGLX is not doing good in the industry: 64.29% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-12.32%
ROE	-17.15%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of AGLX (38.78%) is worse than 64.29% of its industry peers.

In the last couple of years the Gross Margin of AGLX has grown nicely.

The Profit Margin and Operating Margin are not available for AGLX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	38.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y36.08%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AGLX does not have a ROIC to compare to the WACC, probably because it is not profitable.

AGLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 4.51 indicates that AGLX is not in any danger for bankruptcy at the moment.

AGLX has a Altman-Z score of 4.51. This is amongst the best in the industry. AGLX outperforms 97.62% of its industry peers.

AGLX has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.

AGLX has a Debt to Equity ratio of 0.36. This is in the better half of the industry: AGLX outperforms 78.57% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Altman-Z	4.51

ROIC/WACCN/A

WACC8.57%

2.3 Liquidity

A Current Ratio of 30.16 indicates that AGLX has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 30.16, AGLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

AGLX has a Quick Ratio of 30.16. This indicates that AGLX is financially healthy and has no problem in meeting its short term obligations.

AGLX has a better Quick ratio (30.16) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	30.16
Quick Ratio	30.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AGLX have decreased strongly by -121.20% in the last year.

Looking at the last year, AGLX shows a very negative growth in Revenue. The Revenue has decreased by -84.98% in the last year.

AGLX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -40.89% yearly.

EPS 1Y (TTM)-121.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%8.26%

Revenue 1Y (TTM)-84.98%

Revenue growth 3Y-40.89%

Revenue growth 5YN/A

Sales Q2Q%-12.66%

3.2 Future

The Earnings Per Share is expected to grow by 29.00% on average over the next years. This is a very strong growth

AGLX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.82% yearly.

EPS Next Y-2.56%

EPS Next 2Y18.39%

EPS Next 3Y12.82%

EPS Next 5Y29%

Revenue Next Year-91.49%

Revenue Next 2Y-29.06%

Revenue Next 3Y-6.81%

Revenue Next 5Y20.82%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AGLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AGLX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AGLX's earnings are expected to grow with 12.82% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y18.39%

EPS Next 3Y12.82%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AGLX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AGILYX ASA

OSL:AGLX (11/27/2025, 11:49:14 AM)

23.475

+0.08 (+0.32%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)08-21 2025-08-21

Earnings (Next)04-22 2026-04-22/amc

Inst Owners23.46%

Inst Owner ChangeN/A

Ins Owners0.44%

Ins Owner ChangeN/A

Market Cap2.94B

Revenue(TTM)953.00K

Net Income(TTM)-22.14M

Analysts85

Price Target35.19 (49.9%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-6.12%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-1.69%

EPS NY rev (3m)-22.45%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-32.86%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	301.74
P/FCF	N/A
P/OCF	N/A
P/B	2.23
P/tB	2.27
EV/EBITDA	N/A

EPS(TTM)-2.15

EYN/A

EPS(NY)-1.22

Fwd EYN/A

FCF(TTM)-0.59

FCFYN/A

OCF(TTM)-0.59

OCFYN/A

SpS0.08

BVpS10.53

TBVpS10.32

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-12.32%
ROE	-17.15%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	38.78%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y36.08%

GM growth 5YN/A

F-Score3

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	10.44%
Cap/Sales	7.39%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	30.16
Quick Ratio	30.16
Altman-Z	4.51

F-Score3

WACC8.57%

ROIC/WACCN/A

Cap/Depr(3y)323.04%

Cap/Depr(5y)265.24%

Cap/Sales(3y)48.68%

Cap/Sales(5y)33.04%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-121.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%8.26%

EPS Next Y-2.56%

EPS Next 2Y18.39%

EPS Next 3Y12.82%

EPS Next 5Y29%

Revenue 1Y (TTM)-84.98%

Revenue growth 3Y-40.89%

Revenue growth 5YN/A

Sales Q2Q%-12.66%

Revenue Next Year-91.49%

Revenue Next 2Y-29.06%

Revenue Next 3Y-6.81%

Revenue Next 5Y20.82%

EBIT growth 1Y57.54%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year32%

EBIT Next 3Y27.06%

EBIT Next 5Y20.5%

FCF growth 1Y70.36%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y62.52%

OCF growth 3YN/A

OCF growth 5YN/A

AGILYX ASA / AGLX.OL FAQ

Can you provide the ChartMill fundamental rating for AGILYX ASA?

ChartMill assigns a fundamental rating of 3 / 10 to AGLX.OL.

Can you provide the valuation status for AGILYX ASA?

ChartMill assigns a valuation rating of 0 / 10 to AGILYX ASA (AGLX.OL). This can be considered as Overvalued.

How profitable is AGILYX ASA (AGLX.OL) stock?

AGILYX ASA (AGLX.OL) has a profitability rating of 1 / 10.

What is the earnings growth outlook for AGILYX ASA?

The Earnings per Share (EPS) of AGILYX ASA (AGLX.OL) is expected to decline by -2.56% in the next year.

AGILYX ASA (AGLX.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AGILYX ASA / AGLX.OL FAQ

Can you provide the ChartMill fundamental rating for AGILYX ASA?

Can you provide the valuation status for AGILYX ASA?

How profitable is AGILYX ASA (AGLX.OL) stock?

What is the earnings growth outlook for AGILYX ASA?